Allspring Global Investments Holdings LLC Buys 52,696 Shares of Perrigo Company plc (NYSE:PRGO)

Allspring Global Investments Holdings LLC increased its stake in shares of Perrigo Company plc (NYSE:PRGO) by 5.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,092,398 shares of the company’s stock after acquiring an additional 52,696 shares during the quarter. Allspring Global Investments Holdings LLC owned approximately 0.80% of Perrigo worth $28,402,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of the stock. Pacer Advisors Inc. grew its position in Perrigo by 2.1% in the 4th quarter. Pacer Advisors Inc. now owns 20,337 shares of the company’s stock valued at $523,000 after purchasing an additional 427 shares during the period. Wealth Enhancement Advisory Services LLC increased its position in shares of Perrigo by 2.1% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 21,617 shares of the company’s stock worth $567,000 after acquiring an additional 436 shares in the last quarter. Voisard Asset Management Group Inc. raised its holdings in shares of Perrigo by 9.7% in the 3rd quarter. Voisard Asset Management Group Inc. now owns 5,100 shares of the company’s stock worth $134,000 after acquiring an additional 450 shares during the last quarter. Central Pacific Bank Trust Division lifted its position in Perrigo by 33.3% in the 4th quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company’s stock valued at $51,000 after acquiring an additional 500 shares in the last quarter. Finally, Creative Planning boosted its stake in Perrigo by 3.7% during the 3rd quarter. Creative Planning now owns 18,477 shares of the company’s stock valued at $485,000 after purchasing an additional 661 shares during the last quarter. 95.91% of the stock is currently owned by institutional investors and hedge funds.

Perrigo Stock Down 1.3 %

PRGO stock opened at $24.48 on Friday. Perrigo Company plc has a 1-year low of $23.14 and a 1-year high of $33.46. The stock has a market cap of $3.34 billion, a P/E ratio of -20.93 and a beta of 0.54. The stock’s fifty day simple moving average is $25.25 and its two-hundred day simple moving average is $26.37. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94.

Analysts Set New Price Targets

Several analysts have recently commented on PRGO shares. StockNews.com raised Perrigo from a “hold” rating to a “buy” rating in a research note on Monday, February 10th. Argus cut Perrigo from a “buy” rating to a “hold” rating in a research note on Tuesday, January 14th. Finally, Piper Sandler lowered shares of Perrigo from an “overweight” rating to a “neutral” rating and reduced their target price for the stock from $34.00 to $27.00 in a research note on Monday, January 6th. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, Perrigo currently has a consensus rating of “Moderate Buy” and an average price target of $35.00.

Insider Activity at Perrigo

In other Perrigo news, Director Jeffrey B. Kindler sold 17,598 shares of the business’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $28.27, for a total value of $497,495.46. Following the transaction, the director now directly owns 5,409 shares in the company, valued at $152,912.43. The trade was a 76.49 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.70% of the stock is owned by company insiders.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.